Schematic illustration of ADAM12 indicating the published breast cancer-associated mutations and the di-leucine motif in the cytoplasmic tail.

Dorte Stautz (321352)
Ulla M. Wewer (321354)
Marie Kveiborg (228740)

Publication date

February 2013

DOI

10.1371/journal.pone.0037628.g001

Abstract

<p>Schematic illustration of the domain organization of ADAM12. S: Signal peptide; Pro: Prodomain; Met: Metalloprotease domain; Dis: Disintegrin domain; Cys: Cysteine-rich domain; EGF: EGF-like domain; TM: Transmembrane domain; Cyt: Cytoplasmic tail. Positions of the three breast cancer-associated mutations are indicated and the amino acid sequence containing the di-leucine motif is shown.</p

Extracted data

We use cookies to provide a better user experience.

Data Protection

Schematic illustration of ADAM12 indicating the published breast cancer-associated mutations and the di-leucine motif in the cytoplasmic tail.

Abstract

Extracted data

Schematic illustration of ADAM12 indicating the published breast cancer-associated mutations and the di-leucine motif in the cytoplasmic tail.

Abstract

Extracted data

Related items

Related items